Teamed up to innovate
Lab Matters A new formal collaboration agreement enables will help smooth the transition from fundamental science to innovation.
2022
lab-matters
Investing in Italy by translating EMBL expertise to the market
Alumni, Lab Matters, Technology and innovation Experiences at EMBL Rome led former group leader to establish his start-up in Italy, developing a new generation of gene therapies.
2022
alumnilab-matterstechnology-and-innovation
Cell sorting enters a new dimension
Science EMBL researchers, in collaboration with BD Biosciences, have demonstrated a new technology that allows rapid image-based sorting of cells. The new technology represents a major upgrade to flow cytometry and has applications in diverse life science fields.
2022
science
Celebrating Lithuania-EMBL cooperation on life science research
Events EMBL has taken another step towards strengthening its scientific relationship with Lithuania.
2021
events
Structural biology at EMBL: driving technology development
Lab Matters Florent Cipriani, who recently retired as Head of the Instrumentation Team after a long career at EMBL Grenoble, is one of the pioneers of instrumentation development in this field.
2021
lab-matters
Twenty years of EMBLEM
Lab Matters Reflecting on 20 years of EMBLEM
2019
lab-matters
Welcome: Sarah Butcher
Lab Matters Building bridges between scientists and software developers
2018
lab-matters
EMBL spin-off Luxendo acquired by Bruker
Lab Matters Accelerating researchers’ access to next-generation light-sheet microscopy
2017
lab-matters
SPIM doctors
Science From initial development to a start-up company: Selective Plane Illumination Microscopy (SPIM) at EMBL.
2015
science
Lighting the way
Lab Matters A microscopy technique is poised to shine new light on biological questions: as sheets of light can scan everything from developing embryos to single cells or functioning brains, a technique called light-sheet microscopy is gaining traction. It enables scientists to observe living cells in three…
2015
lab-matters
Decoding disease
Alumni Behind the scenes of start-up Miroculus, developing a non-invasive test for early-stage disease.
2015
alumni
No matching posts found
